Annual Current Liabilities
$143.84 M
+$22.42 M+18.46%
December 31, 2023
Summary
- As of February 7, 2025, BBIO annual total current liabilities is $143.84 million, with the most recent change of +$22.42 million (+18.46%) on December 31, 2023.
- During the last 3 years, BBIO annual current liabilities has risen by +$48.20 million (+50.39%).
- BBIO annual current liabilities is now at all-time high.
Performance
BBIO Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$139.22 M
+$4.85 M+3.61%
September 30, 2024
Summary
- As of February 7, 2025, BBIO quarterly total current liabilities is $139.22 million, with the most recent change of +$4.85 million (+3.61%) on September 30, 2024.
- Over the past year, BBIO quarterly current liabilities has dropped by -$4.63 million (-3.22%).
- BBIO quarterly current liabilities is now -3.22% below its all-time high of $143.84 million, reached on December 31, 2023.
Performance
BBIO Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
BBIO Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +18.5% | -3.2% |
| 3 y3 years | +50.4% | -3.2% |
| 5 y5 years | +341.6% | -3.2% |
BBIO Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +18.5% | -3.2% | +44.1% |
| 5 y | 5-year | at high | +138.2% | -3.2% | +130.6% |
| alltime | all time | at high | +1582.4% | -3.2% | +327.3% |
BridgeBio Pharma Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $139.22 M(+3.6%) |
| Jun 2024 | - | $134.36 M(-5.0%) |
| Mar 2024 | - | $141.48 M(-1.6%) |
| Dec 2023 | $143.84 M(+18.5%) | $143.84 M(+35.6%) |
| Sep 2023 | - | $106.06 M(-3.7%) |
| Jun 2023 | - | $110.12 M(+14.0%) |
| Mar 2023 | - | $96.60 M(-20.4%) |
| Dec 2022 | $121.43 M(-10.1%) | $121.43 M(+1.9%) |
| Sep 2022 | - | $119.19 M(-15.6%) |
| Jun 2022 | - | $141.16 M(+36.4%) |
| Mar 2022 | - | $103.46 M(-23.4%) |
| Dec 2021 | $135.07 M | $135.07 M(+41.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2021 | - | $95.82 M(-27.4%) |
| Jun 2021 | - | $131.91 M(+39.2%) |
| Mar 2021 | - | $94.73 M(-1.0%) |
| Dec 2020 | $95.65 M(+58.4%) | $95.65 M(+26.3%) |
| Sep 2020 | - | $75.71 M(-18.3%) |
| Jun 2020 | - | $92.64 M(+42.7%) |
| Mar 2020 | - | $64.91 M(+7.5%) |
| Dec 2019 | $60.38 M(+85.4%) | $60.38 M(+51.5%) |
| Sep 2019 | - | $39.86 M(+3.0%) |
| Jun 2019 | - | $38.70 M(+9.1%) |
| Mar 2019 | - | $35.47 M(+8.9%) |
| Dec 2018 | $32.58 M(+281.0%) | $32.58 M |
| Dec 2017 | $8.55 M | - |
FAQ
- What is BridgeBio Pharma annual total current liabilities?
- What is the all time high annual current liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma annual current liabilities year-on-year change?
- What is BridgeBio Pharma quarterly total current liabilities?
- What is the all time high quarterly current liabilities for BridgeBio Pharma?
- What is BridgeBio Pharma quarterly current liabilities year-on-year change?
What is BridgeBio Pharma annual total current liabilities?
The current annual current liabilities of BBIO is $143.84 M
What is the all time high annual current liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high annual total current liabilities is $143.84 M
What is BridgeBio Pharma annual current liabilities year-on-year change?
Over the past year, BBIO annual total current liabilities has changed by +$22.42 M (+18.46%)
What is BridgeBio Pharma quarterly total current liabilities?
The current quarterly current liabilities of BBIO is $139.22 M
What is the all time high quarterly current liabilities for BridgeBio Pharma?
BridgeBio Pharma all-time high quarterly total current liabilities is $143.84 M
What is BridgeBio Pharma quarterly current liabilities year-on-year change?
Over the past year, BBIO quarterly total current liabilities has changed by -$4.63 M (-3.22%)